9.5% CAGR for Narcolepsy Market to Account to US$ 4,537.9 Million by 2027 - Bioprojet, Jazz Pharmaceuticals, Graymark Healthcare, Arena Pharmaceuticals
Global narcolepsy market is expected to reach US$ 4,537.9 Mn in 2027 from US$ 2,026.8 Mn in 2018 with a CAGR of 9.5. The report highlights the trends prevalent in the global narcolepsy market and the factors driving the market along with those that act as deterrents to its growth.
View full press release